HALIFAX, NS, March 23, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces today that its wholly owned subsidiary has increased its ownership of Knight Therapeutics Inc. (“Knight”) to over 10% of Knight’s outstanding common shares.